Medicure (MCUJF) Shares Outstanding (Diluted Average) (2012 - 2026)
Medicure (MCUJF) recorded quarterly Shares Outstanding (Diluted Average) of $29.17 in Q1 2026, down 94.02% quarter-over-quarter from $487.62 in Q4 2025, and down 40.21% on a YoY basis from $48.78 in Q1 2025.
Medicure (MCUJF) Shares Outstanding (Diluted Average) (2012 - 2026) Analysis & Trends
Medicure's Shares Outstanding (Diluted Average) history runs 15 years deep, the most recent figure standing at $29.17 for Q1 2026.
- In Q1 2026, Shares Outstanding (Diluted Average) fell 40.21% year-over-year to $29.17; the TTM figure through Mar 2026 stood at $29.17 (down 40.21% YoY), while the FY2025 annual figure was $487.62, up 581.18% from the prior year.
- Shares Outstanding (Diluted Average) was $29.17 for Q1 2026 at Medicure, down from $487.62 in the prior quarter.
- In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $487.62 in Q4 2025 to a low of $7.33 in Q3 2024.
- Historically, Shares Outstanding (Diluted Average) has averaged $80.31 across 5 years, with a median of $47.92 in 2025.
- The sharpest annual moves came in 2024 and 2025: Shares Outstanding (Diluted Average) plunged 80.35% in 2024, then soared 581.18% in 2025.
- A 5-year view of Shares Outstanding (Diluted Average) shows it stood at $95.77 in 2022, then sank by 30.97% to $66.11 in 2023, then climbed by 8.28% to $71.58 in 2024, then soared by 581.18% to $487.62 in 2025, then sank by 94.02% to $29.17 in 2026.
- The last three Shares Outstanding (Diluted Average) figures came in at $29.17 (Q1 2026), $487.62 (Q4 2025), and $101.04 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares (Diluted Avg.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 1.18 Bn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | 422.40 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | 47.20 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 103.40 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | 506.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | - |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | 228.36 Mn |
| 10 | Medicure | - | - | 2.57 Mn | 29.17 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 29.17 |
| Dec 31, 2025 | 487.62 |
| Jun 30, 2025 | 101.04 |
| Mar 31, 2025 | 48.78 |
| Dec 31, 2024 | 71.58 |
| Sep 30, 2024 | 7.33 |
| Jun 30, 2024 | 87.74 |
| Mar 31, 2024 | 22.26 |
| Dec 31, 2023 | 66.11 |
| Sep 30, 2023 | 37.30 |
| Jun 30, 2023 | 37.22 |
| Mar 31, 2023 | 22.19 |
| Dec 31, 2022 | 95.77 |
| Sep 30, 2022 | 84.34 |
| Jun 30, 2022 | 47.06 |
| Mar 31, 2022 | 39.47 |
| Dec 31, 2021 | 55.53 |
| Sep 30, 2021 | 206.55 |
| Jun 30, 2021 | 130.16 |
| Mar 31, 2021 | 79.01 |